Company Filing History:
Years Active: 2020
Title: Audra Lynn Strinchcomb: Innovator in Cannabidiol Prodrugs
Introduction
Audra Lynn Strinchcomb is a notable inventor based in Towson, Maryland. She has made significant contributions to the field of pharmaceuticals, particularly in the development of cannabidiol prodrugs. Her innovative work aims to enhance drug delivery systems for various medical applications.
Latest Patents
Strinchcomb holds a patent for the "Use of Cannabidiol Prodrugs in Pharmaceutical Compositions." This patent describes the use of cannabidiol prodrugs in pharmaceutical compositions, as well as microneedle drug delivery systems. These systems are designed to deliver active agents, such as cannabidiol and its prodrugs, effectively to mammals. The patent also outlines methods for using microneedle transdermal or topical drug delivery systems in treating diseases, including pancreatitis and pancreatic cancer.
Career Highlights
Audra Lynn Strinchcomb is currently associated with Zynerba Pharmaceuticals, Inc., where she continues to advance her research in pharmaceutical innovations. Her work focuses on improving drug delivery mechanisms to enhance therapeutic outcomes for patients.
Collaborations
Strinchcomb has collaborated with notable professionals in her field, including Stan Lee Banks and Miroslaw Jerzy Golinski. These collaborations have contributed to her research and development efforts in the pharmaceutical industry.
Conclusion
Audra Lynn Strinchcomb is a pioneering inventor whose work in cannabidiol prodrugs and drug delivery systems is making a significant impact in the pharmaceutical field. Her innovative approaches hold promise for improving treatment options for various diseases.